Search

Breakthrough results in quadruplex science! A research group at the University of Cambridge found quadruplex-stranded DNA in healthy human cells for the first time, as displayed in their publication in Nature. University of Cambridge researchers directly observed DNA quadruplex structures as controllers of gene expression in human cells. First author Marco Di Antonio states that “this forces us to rethink the biology of DNA.”


This finding confirms the revolutionary discoveries made by Reglagene’s CSO Laurence Hurley. Reglagene was founded on the thought of targeting quadruplex structures in cancer genes. By doing this, we can target specific genes and regulate their protein production. Today, Reglagene applies Quadruplex Master Switch Technology (QMST) to create and develop Epigenetic Medicines that save patient lives.

Read more: https://www.newscientist.com/article/2249390-quadruple-stranded-dna-seen-in-healthy-human-cells-for-the-first-time/#ixzz6SrxqJxrn


In April, Reglagene participated in their most successful partnering event to date. Reglagene's CEO Richard Austin had 25 investor partnering meetings in a two day period! Part of this success came from updated pitch decks, executive summaries, and a new tagline, while other successes came from how Reglagene engages with investors throughout the entire process.


Karen Deyo, the Senior Investor Research Analyst at LSN interviewed Richard about his experience and how he pulled off such an incredible two day event.


Click the link below to read the full the interview.


https://blog.lifesciencenation.com/2020/05/07/reglagene-nails-resi-partnering-with-25-investor-meetings/

Updated: Jun 1

"At Reglagene, our dream is not cancer treatments, it is cancer cures!" -Richard Austin


The Cancer Fund's Ann Low interviewed Reglagene's CEO Richard Austin. Watch it here for more background about Reglagene's biotechnology and information on Reglagene's first product!



OFFICE

1703 E Mabel St
Tucson, AZ 85721
USA

www.reglagene.com  |  https://www.linkedin.com/company/reglagene/ | ©2020 by Reglagene Holding, Inc.